OraSure reports Q1 EPS (18c), consensus (12c)

Reports Q1 revenue $29.93M, consensus $29.57M. “Our Q1 results were consistent with our expectations. Our customers continue to demonstrate their preference for our differentiated products in delivering on their important health objectives, even while uncertainty remains elevated related to government funding sources for some segments,” said OraSure (OSUR) President and CEO Carrie Eglinton Manner. “We are making good progress in advancing our innovation roadmap, including multiple new product milestones planned in 2025, and OTI is positioned to deliver accelerated growth in our core business in the coming years.”